COSCIENS Biopharma Inc. (TSX:CSCI)

Canada · Delayed Price · Currency is CAD

2.850

+0.020 (0.71%)

Apr 10, 2026, 3:13 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Active Ingredient	7.04M	8.49M	7.14M	14.57M	-
Active Ingredient Growth	-17.13%	18.89%	-50.98%	-	-
Biopharmaceutical	461.00K	1.10M	-	-	5.26M
Biopharmaceutical Growth	-57.90%	-	-	-	44.03%
Total	7.50M	9.59M	7.14M	14.57M	5.26M
Total Growth	-21.79%	34.22%	-50.98%	177.03%	44.03%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	4.60M	6.69M	3.42M	8.60M	-
United States Growth	-31.19%	95.87%	-60.28%	-	-
Germany	2.38M	1.36M	3.56M	4.56M	-
Germany Growth	74.85%	-61.83%	-21.92%	-	-
United Kingdom	457.00K	976.00K	-	-	-
United Kingdom Growth	-53.18%	-	-	-	-
Other	59.00K	260.00K	164.00K	83.00K	-
Other Growth	-77.31%	58.54%	97.59%	-	-
Colombia	-	300.00K	-	-	-
China	-	-	-	1.33M	-
Switzerland	-	-	-	-	5.08M
Switzerland Growth	-	-	-	-	460.77%
Denmark	-	-	-	-	185.00K
Denmark Growth	-	-	-	-	-93.03%
Total	7.50M	9.59M	7.14M	14.57M	5.26M
Total Growth	-21.79%	34.22%	-50.98%	177.03%	44.03%

Source: S&P Global Market Intelligence.